GBS Venture Partners

GBS Venture Partners or GBS is a venture capital firmventure capital firm focused on private or public companies in areas of human healthcare, biotechnology product development, and life science.

Its investments include Moximed, Elastagen, IvantisIvantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.

Brigitte Smith and Geoff Brooke founded GBS Venture Partners in 1996. It invests in companies developing and commercializing biological or small molecule therapeutics, medical devices, and diagnostics products in AustraliaAustralia. Its previous funds include The Australian, Bioscience Trust , GBS Bioventures II , The Genesis Fund , and GBS Bioventures III .

Its investments include Moximed, Elastagen, Ivantis, AirXpandersAirXpanders, Spinifex Pharmaceuticals, and Neurovance.

Its investments include MoximedMoximed, Elastagen, Ivantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.

GBS Venture Partners or GBS is a venture capital firm focused on private or public companies in areas of human healthcare, biotechnology product development, and life science.

Brigitte Smith and Geoff Brooke founded GBS Venture Partners in 1996. It invests in companies developing and commercializing biological or small molecule therapeutics, medical devices, and diagnostics products in Australia. Its previous funds include The Australian, Bioscience Trust , GBS Bioventures II , The Genesis Fund , and GBS Bioventures III .

The GBS team provides strategic advice and support to portfolio companies, access specialist scientific and technical advice and introductions to international contacts and corporate collaborators .

Its investments include Moximed, Elastagen, Ivantis, AirXpanders, Spinifex Pharmaceuticals, and Neurovance.